Feline Serum Amyloid A (fSAA)
Feline serum amyloid A is a major acute-phase protein; quantitative measurement supports early detection and monitoring of inflammation in cats.
Fact Table
| Species | Feline |
|---|---|
| Biomarker | Serum amyloid A (SAA) |
| Method | Fluorescence immunoassay (FICT) |
| Unit | mg/L |
| Category | Inflammatory |
Clinical Context
Feline serum amyloid A is a major acute-phase protein; quantitative measurement supports early detection and monitoring of inflammation in cats.
Interpretation should always combine the quantitative result with the patient's signalment, history, clinical signs, and any other laboratory findings. A single value is rarely diagnostic on its own; serial measurements often provide more useful information.
Reference Range
Reference ranges vary by species, age and laboratory method — always interpret against the kit IFU and your in-house validation.
Related Test Kits
Related Articles
Manufacturer documentation + clinical literature cited in related articles
2026-09-12
MEDIUM — reference ranges are method-specific
FAQ
What does the Feline Serum Amyloid A (fSAA) test measure?
Migibio's Feline Serum Amyloid A (fSAA) test is a quantitative fluorescence immunoassay (FICT) run on the FIA680/FIA880 analyzer. It is intended as an aid in clinical assessment: Feline serum amyloid A is a major acute-phase protein; quantitative measurement supports early detection and monitoring of inflammation in cats. The exact specimen, sample handling, and reporting units are specified in the kit IFU.
When is feline SAA testing most useful?
When systemic inflammation is suspected or to monitor response to treatment, surgery, or infection. A baseline and serial measurements help distinguish resolving from persistent inflammation. For cats, use the result with the clinical history, physical examination, and any other laboratory findings.
Why does this Data Hub not publish a universal reference range?
Reference ranges vary by species, age and laboratory method — always interpret against the kit IFU and your in-house validation.